Aytac, H.Camyar, A.Ozisik, M.Gokmen, Mete E. N.Sin, A. Z.2019-10-272019-10-2720190105-45381398-9995https://hdl.handle.net/11454/28734Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI) -- JUN 01-05, 2019 -- Lisbon, PORTUGALeninfo:eu-repo/semantics/closedAccessFactors affecting response and recurrence in omalizumab treatment (Late Breaking Abstract)Conference Object74186186WOS:000480254001107Q1